Baytril 25 mg/ml solution for injection

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Δραστική ουσία:

Enrofloxacin

Διαθέσιμο από:

Elanco GmbH

Φαρμακολογική κατηγορία (ATC):

QJ01MA90

INN (Διεθνής Όνομα):

Enrofloxacin

Δοσολογία:

25 milligram(s)/millilitre

Φαρμακοτεχνική μορφή:

Solution for injection

Τρόπος διάθεσης:

POM: Prescription Only Medicine as defined in relevant national legislation

Θεραπευτική περιοχή:

enrofloxacin

Καθεστώς αδειοδότησης:

Authorised

Ημερομηνία της άδειας:

1988-10-01

Αρχείο Π.Χ.Π.

Health Products Regulatory Authority
SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE VETERINARY MEDICINAL PRODUCT
Baytril 25 mg/ml solution for injection
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml solution contains:
ACTIVE SUBSTANCE:
Enrofloxacin 25 mg
EXCIPIENT:
n-Butyl alcohol 30 mg
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Solution for injection.
Clear light-yellow solution.
4
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs, cats, pigs (piglets), rabbits, rodents, reptiles and ornamental
birds.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Dogs
Treatment of infections of the alimentary, respiratory and urogenital
tracts (including prostatitis, adjunctive antibiotic therapy
for pyometra), skin and wound infections, otitis (externa/media)
caused by enrofloxacin susceptible strains of: _Staphylococcus _
spp_., Escherichia coli, Pasteurella _spp_., Klebsiella _spp_.,
Bordetella _spp_., Pseudomonas _spp_. _and _Proteus _spp_. _
_ _
Cats
Treatment of infections of the alimentary, respiratory and urogenital
tracts (as adjunctive antibiotic therapy for pyometra), skin
and wound infections, caused by enrofloxacin susceptible strains of:
_Staphylococcus _spp_., Escherichia coli, Pasteurella _spp_., _
_Klebsiella _spp_., Bordetella _spp_., Pseudomonas _spp_. _and
_Proteus _spp.
Pigs (piglets)
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of: _Pasteurella multocida,
Mycoplasma _
spp_., Actinobacillus pleuropneumoniae_.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli. _
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli_.
Rabbits
Treatment of infections of the alimentary and respiratory tracts
caused by enrofloxacin susceptible strains of: _Escherichia coli_,
_Pasteurella multocida _and _Staphylococcus _spp.
Treatment of skin and wound infections caused byenrofloxacin
susceptible strains of _Staphylococcus aureus. _
_ _
Rodents, repti